Zobrazeno 1 - 9
of 9
pro vyhledávání: '"María Teresa Soler-Monso"'
Autor:
Jorge Gómez-Miragaya, Marta Palafox, Laia Paré, Guillermo Yoldi, Irene Ferrer, Sergi Vila, Patricia Galván, Pasquale Pellegrini, Hector Pérez-Montoyo, Ana Igea, Purificación Muñoz, Manel Esteller, Angel R. Nebreda, Ander Urruticoechea, Idoia Morilla, Sonia Pernas, Fina Climent, María Teresa Soler-Monso, Ana Petit, Violeta Serra, Aleix Prat, Eva González-Suárez
Publikováno v:
Stem Cell Reports, Vol 8, Iss 5, Pp 1392-1407 (2017)
Taxanes are a mainstay of treatment for breast cancer, but resistance often develops followed by metastatic disease and mortality. Aiming to reveal the mechanisms underlying taxane resistance, we used breast cancer patient-derived orthoxenografts (PD
Externí odkaz:
https://doaj.org/article/4f17da8dcc6a4c1abea0af3c702c89e0
Autor:
Eva González-Suárez, Xose S. Puente, Michael T. Lewis, Miguel Angel Pujana, Violeta Serra, Cristina Cruz, Judith Balmaña, Anna Petit, María Teresa Soler-Monso, Joaquín Arribas, Carlos Caldas, Alejandra Bruna, Aleix Prat, Laia Paré, Purificación Muñoz, Eva M. Trinidad, Alejandro Collado-Sole, Gerburg M. Wulf, Bing Zhang, Suhas Vasaikar, Chen Huang, Lacey E. Dobrolecki, Marta Palafox, Luis Palomero, Sergi Beltran, Raul Tonda, Ander Díaz-Navarro, Jorge Gómez-Miragaya
Supplementary methods and legends for supplementary figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c459f478caf89ee13f2a4d0789fe97
https://doi.org/10.1158/0008-5472.22421748.v1
https://doi.org/10.1158/0008-5472.22421748.v1
Autor:
Eva González-Suárez, Xose S. Puente, Michael T. Lewis, Miguel Angel Pujana, Violeta Serra, Cristina Cruz, Judith Balmaña, Anna Petit, María Teresa Soler-Monso, Joaquín Arribas, Carlos Caldas, Alejandra Bruna, Aleix Prat, Laia Paré, Purificación Muñoz, Eva M. Trinidad, Alejandro Collado-Sole, Gerburg M. Wulf, Bing Zhang, Suhas Vasaikar, Chen Huang, Lacey E. Dobrolecki, Marta Palafox, Luis Palomero, Sergi Beltran, Raul Tonda, Ander Díaz-Navarro, Jorge Gómez-Miragaya
Docetaxel response on TNBC cell lines with ETV6 and GABARAPL1 overexpression and knockdown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a8c8345a1ddeb9a7b70d6b65550935a
https://doi.org/10.1158/0008-5472.22421757
https://doi.org/10.1158/0008-5472.22421757
Autor:
Eva González-Suárez, Xose S. Puente, Michael T. Lewis, Miguel Angel Pujana, Violeta Serra, Cristina Cruz, Judith Balmaña, Anna Petit, María Teresa Soler-Monso, Joaquín Arribas, Carlos Caldas, Alejandra Bruna, Aleix Prat, Laia Paré, Purificación Muñoz, Eva M. Trinidad, Alejandro Collado-Sole, Gerburg M. Wulf, Bing Zhang, Suhas Vasaikar, Chen Huang, Lacey E. Dobrolecki, Marta Palafox, Luis Palomero, Sergi Beltran, Raul Tonda, Ander Díaz-Navarro, Jorge Gómez-Miragaya
Taxanes are the mainstay of treatment in triple-negative breast cancer (TNBC), with de novo and acquired resistance limiting patient's survival. To investigate the genetic basis of docetaxel resistance in TNBC, exome sequencing was performed on match
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98573ba4edc3d2e2455e34f8453a5f5e
https://doi.org/10.1158/0008-5472.c.6511020
https://doi.org/10.1158/0008-5472.c.6511020
Autor:
Eva González-Suárez, Xose S. Puente, Michael T. Lewis, Miguel Angel Pujana, Violeta Serra, Cristina Cruz, Judith Balmaña, Anna Petit, María Teresa Soler-Monso, Joaquín Arribas, Carlos Caldas, Alejandra Bruna, Aleix Prat, Laia Paré, Purificación Muñoz, Eva M. Trinidad, Alejandro Collado-Sole, Gerburg M. Wulf, Bing Zhang, Suhas Vasaikar, Chen Huang, Lacey E. Dobrolecki, Marta Palafox, Luis Palomero, Sergi Beltran, Raul Tonda, Ander Díaz-Navarro, Jorge Gómez-Miragaya
Supplementary Table S1. Models, point mutations and CNA Supplementary Table S2. Differentially expressed genes, pathways and co-occurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f9c874c83d95ae28fdf557fd4a36fd4
https://doi.org/10.1158/0008-5472.22421751
https://doi.org/10.1158/0008-5472.22421751
Autor:
Anna Petit, Eva González-Suárez, Gerburg M. Wulf, Bing Zhang, Carlos Caldas, Michael T. Lewis, Joaquín Arribas, Xose S. Puente, Eva M. Trinidad, Luis Palomero, Judith Balmaña, María Teresa Soler-Monso, Marta Palafox, Lacey E. Dobrolecki, Alejandra Bruna, Suhas Vasaikar, Aleix Prat, Violeta Serra, Ander Diaz-Navarro, Jorge Gomez-Miragaya, Laia Paré, Sergi Beltran, Alejandro Collado-Sole, Purificación Muñoz, Raul Tonda, Miguel Angel Pujana, Chen Huang, Cristina Cruz
Publikováno v:
Cancer Research. 79:4258-4270
Taxanes are the mainstay of treatment in triple-negative breast cancer (TNBC), with de novo and acquired resistance limiting patient's survival. To investigate the genetic basis of docetaxel resistance in TNBC, exome sequencing was performed on match
Autor:
Jorge, Gómez-Miragaya, Ander, Díaz-Navarro, Raul, Tonda, Sergi, Beltran, Luis, Palomero, Marta, Palafox, Lacey E, Dobrolecki, Chen, Huang, Suhas, Vasaikar, Bing, Zhang, Gerburg M, Wulf, Alejandro, Collado-Sole, Eva M, Trinidad, Purificación, Muñoz, Laia, Paré, Aleix, Prat, Alejandra, Bruna, Carlos, Caldas, Joaquín, Arribas, María Teresa, Soler-Monso, Anna, Petit, Judith, Balmaña, Cristina, Cruz, Violeta, Serra, Miguel Angel, Pujana, Michael T, Lewis, Xose S, Puente, Eva, González-Suárez
Publikováno v:
Cancer research. 79(16)
Taxanes are the mainstay of treatment in triple-negative breast cancer (TNBC), with
Autor:
Adrián Sanz-Moreno, Sonia Palomeras, Kim Pedersen, Beatriz Morancho, Tomas Pascual, Patricia Galván, Sandra Benítez, Jorge Gomez-Miragaya, Marina Ciscar, Maria Jimenez, Sonia Pernas, Anna Petit, María Teresa Soler-Monsó, Gemma Viñas, Mansour Alsaleem, Emad A. Rakha, Andrew R. Green, Patricia G. Santamaria, Celine Mulder, Simone Lemeer, Joaquin Arribas, Aleix Prat, Teresa Puig, Eva Gonzalez-Suarez
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-18 (2021)
Abstract Background Around 15–20% of primary breast cancers are characterized by HER2 protein overexpression and/or HER2 gene amplification. Despite the successful development of anti-HER2 drugs, intrinsic and acquired resistance represents a major
Externí odkaz:
https://doaj.org/article/30beb90cbbc444768fc569001a4484a0
Autor:
María Teresa Soler-Monso, Violeta Serra, Manel Esteller, Marta Palafox, Héctor Pérez-Montoyo, Ana Igea, Jorge Gomez-Miragaya, Eva González-Suárez, Sergi Vila, Ana Petit, Ander Urruticoechea, Purificación Muñoz, Aleix Prat, Guillermo Yoldi, Sonia Pernas, Idoia Morilla, Fina Climent, Irene Ferrer, Laia Paré, Angel R. Nebreda, Patricia Galván, Pasquale Pellegrini
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Stem Cell Reports
Dipòsit Digital de la UB
Universidad de Barcelona
Stem Cell Reports, Vol 8, Iss 5, Pp 1392-1407 (2017)
instname
Stem Cell Reports
Dipòsit Digital de la UB
Universidad de Barcelona
Stem Cell Reports, Vol 8, Iss 5, Pp 1392-1407 (2017)
Summary Taxanes are a mainstay of treatment for breast cancer, but resistance often develops followed by metastatic disease and mortality. Aiming to reveal the mechanisms underlying taxane resistance, we used breast cancer patient-derived orthoxenogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc286606b599ec48b871a18397f404d
http://hdl.handle.net/2445/130119
http://hdl.handle.net/2445/130119